About LBT Innovations
LBT Innovations is a company based in Adelaide (Australia) founded in 2004. LBT Innovations has completed 1 acquisition, including Clever Culture Systems. LBT Innovations offers products and services including APAS Independence. LBT Innovations operates in a competitive market with competitors including MaxCyte, SQZBiotech, Berkeley Lights, Gemini Bio and Fluxion Biosciences, among others.
- Headquarter Adelaide, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$942.18 K (USD), Grant
Oct 21, 2022
-
Investors
MTPConnect
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LBT Innovations
LBT Innovations offers a comprehensive portfolio of products and services, including APAS Independence.
Automates imaging and analysis of microbiology culture plates for labs.
People of LBT Innovations
Unlock access to complete
Unlock access to complete
Funding Insights of LBT Innovations
Investors in LBT Innovations
LBT Innovations has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include MTPConnect and SA.GOV.AU.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Australia's life sciences innovation is accelerated by MTPConnect.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for LBT Innovations
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LBT Innovations
LBT Innovations has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Clever Culture Systems.
Investment portfolio details for LBT Innovations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Automated microbiology solutions for infectious disease diagnostics are developed.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for LBT Innovations
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - LBT Innovations
Detailed financials for LBT Innovations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lbt Innovations Comparisons
Peer comparison for LBT Innovations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LBT Innovations
LBT Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Berkeley Lights, Gemini Bio and Fluxion Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for cell processing and modification are provided.
|
|
| Locked | Locked | Locked |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| Locked | Locked | Locked |
Microfluidics-based systems for single-cell isolation and analysis are developed.
|
|
| Locked | Locked | Locked |
Supplement reagents for cell and gene therapy are manufactured.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
|
| Locked | Locked | Locked |
Developer of automated cell culture instruments
|
Detailed competitors of LBT Innovations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lbt Innovations
Complete news archive for LBT Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LBT Innovations
LBT Innovations was founded in 2004 and raised its 1st funding round 10 years after it was founded.
LBT Innovations is headquartered in Adelaide, Australia. It is registered at Adelaide, South Australia, Australia.
LBT Innovations was founded in 2004 in Adelaide, Australia, and operates in the microbiology sector. Automated solutions based on AI are designed for the preparation and analysis of culture specimens. The initial technology, MicroSteak, handles automated streaking of culture plates. Subsequent developments include the Automated Plate Assessment System (APAS), which captures, analyzes, and interprets images of incubated plates to support workflow efficiency.
LBT Innovations's top competitors include MaxCyte, SQZBiotech and Mytos.
LBT Innovations offers APAS Independence.
LBT Innovations has made 1 acquisition, including Clever Culture Systems.
LBT Innovations has 2 investors. Key investors include MTPConnect, and SA.GOV.AU.